コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 he second mutating and inactivating the cas9 transgene.
2 n which human FcgammaRIIa was expressed as a transgene.
3 sm for human cells that is not mediated by a transgene.
4 on rates of keratinocytes not expressing the transgene.
5 pe of tectal neurons labeled by an id2b:gal4 transgene.
6 tificial chromosome (HAC) expressing the GFP transgene.
7 n comparison with mice harboring only the AR transgene.
8 rotein changes driven by the alpha-synuclein transgene.
9 ts antigenicity-the immunity elicited to the transgene.
10 f a tetracycline-regulatable (Tet-off) v-myc transgene.
11 esis by blocking the expression of the ErbB2 transgene.
12 ineered to express an antigen from a foreign transgene.
13 be inherited even following loss of the CMT3 transgene.
14 inducible tissue-specific expression of PG-1 transgene.
15 lentiviral vector delivery or induction of a transgene.
16 e tracheal AMP gene promoter-controlled PG-1 transgene.
17 es but currently rely on the introduction of transgenes.
18 ranscriptionally active viral and endogenous transgenes.
19 using CRISPR/Cas9 components expressed from transgenes.
20 uce potent immune responses against inserted transgenes.
21 to viruses, transposable elements, and some transgenes.
22 and GR dipeptide production from (G4C2)(30+) transgenes.
23 super-Mendelian inheritance of the separate transgenes.
24 sts expressing DMP1-Cherry and DSPP-Cerulean transgenes.
25 n in backgrounds containing kinetochore RNAi transgenes.
26 on of adeno-associated virus (AAV)-delivered transgenes, allowing dose-dependent and up to 223-fold r
27 worms harboring either the Abeta1-42 or tau transgene alone and interestingly without changes to the
30 GaRe doxycycline inducible SpCas9 (ODInCas9) transgene and its use in targeted ObLiGaRe results in fu
31 nerated mouse model in which both murine Met transgene and stabilized beta-catenin are conditionally
32 g developments in the incorporation of human transgenes and additional mutations in humanized mouse m
33 otypes, T-cell function, immune responses to transgenes and autoantibodies, vector copy number, and i
34 ithout or with SMAD7 (sCYLD/SMAD7 mice) from transgenes and CYLD-knockout mice (with or without trans
38 y of complex VSV recombinants carrying large transgenes and support further clinical development of o
39 RNAs (mRNAs) of a green fluorescent protein transgene, and CD46, CD55 and CD71 cell-surface proteins
40 he tissues of P(1) individuals harboring the transgene, and high transgene expression was observed in
41 defects can be corrected by ASF1A and ASF1B transgenes, and that ASF1A and ASF1B act redundantly.
42 t transcript levels measured adjacent to the transgene are approximately twofold higher for speckle-a
44 Since the discovery two decades ago that transgenes are efficiently integrated into the genome of
45 kout (TKO) pigs (with added protective human transgenes) are likely to be optimal sources of organs f
46 sing CRISPR/Cas9 technology to integrate the transgene at the safe-harbor AAVS1 locus in DLD-1 cells.
48 tionately expanded in mice expressing a Baff transgene (B6.BTg) and were disproportionately contracte
50 its broad tropism can be detrimental if the transgene being delivered is harmful when expressed ubiq
51 This is partially a result of the Pf4-Cre transgene being expressed in a variety of leukocyte popu
53 tested the effectiveness of a single CRISPRi transgene broadly expressing a single guide RNA and a ca
54 is in C. elegans by engineering a multicolor transgene called NeuroPAL (a neuronal polychromatic atla
55 se results demonstrate that a single CRISPRi transgene can effectively suppress a target gene in mice
57 However, these human SMN missense allele transgenes can rescue a null Smn allele when SMN2 is pre
58 tial degree of freedom in the engineering of transgenes capable of simultaneously expressing multiple
60 deliver an instability-prone Mecp2 (iMecp2) transgene cassette which, increasing RNA destabilization
61 V transduction efficiency (by optimizing the transgene cassette), vector tropism (using capsid engine
62 at inactivation of Rb plus p53 via a WAP-Cre transgene, commonly used to target the mammary gland dur
66 mouse embryonic stem cells, expression of a transgene comprising the first two kilobases of Xist (Xi
67 y active KRas (caKRas) allele and the CD4Cre transgene contain not only hyperactivated T cells but al
69 Out of 151 zygotes injected with circular transgene-containing plasmid and Cas9 protein loaded wit
74 vascular BOLA3 was performed by orotracheal transgene delivery of adeno-associated virus in mouse mo
80 protein-coupled receptor kinase 2 (GRK2-DN) transgene diminishes AR and AR target gene expression in
83 e line with a targeted-insertion of the same transgene driven by the same tetracycline-TransActivator
85 y a gene drive either to inactivate the cas9 transgene (e-CHACRs) or to delete and replace the gene d
86 y, while GRASLND overexpression - either via transgene ectopic expression or by endogenous activation
88 bstantially higher levels of the therapeutic transgene, enabling the use of lower and safer vector do
89 The (FSF)TGFbeta(CA) allele consists in a transgene encoding a constitutively active mutant form o
90 n live mice and colon tissues that express a transgene encoding the calcium indicator GCaMP, we visua
92 r are at least partially interchangeable, as transgenes expressing ALA6 in vegetative tissues partial
93 sured by observing the inheritance of linked transgenes expressing different colors of fluorescent pr
94 in a bidirectional manner for bioimaging of transgene-expressing PCs in zebrafish (both sexes) with
96 lymphoid progenitors driven by synthetic CAR transgene expression and encourage further evaluation of
97 rage exhibited more uniform and higher-level transgene expression both in the 3D model and in vivo, w
98 ermissive chromatin structure has assembled, transgene expression can persist even in the absence of
99 juvenile mice results in loss of persistent transgene expression due to hepatocyte proliferation in
100 ides the longest term evidence of persistent transgene expression following gene delivery to the CNS
101 "toolkit" enables efficient transduction and transgene expression from neurons, microglia, astrocytes
102 enhanced delivery (CED), provides widespread transgene expression in heathy rodent striatum and an ag
103 n and that sustaining hypertranscription and transgene expression in hyperproliferative cells early i
104 wherein conditional NeuroD2-controlled REST transgene expression in lineage-committed Ptch1 (+/-) ce
105 r, which specifically and potently sustained transgene expression in mouse RGCs and also works in hum
106 ambient CO(2)) on exogenous Bt toxins and transgene expression in promoterregion and codingregion
108 of a high dose of GAd accomplished extensive transgene expression in the lung yet elicited no detecta
110 transgene mehtylation in promoterregion with transgene expression is even stronger than that in codin
112 ressing asyn have previously been developed, transgene expression is usually driven by pan-neuronal p
113 ransfection efficiency enhancement and rapid transgene expression kinetics of GFP plasmids at no comp
115 and nuclear membrane quickly to promote the transgene expression level and kinetics in both adherent
119 lted in therapeutically inadequate levels of transgene expression or have raised safety concerns asso
120 region of transgene plays a critical role in transgene expression regulation and silencing of transge
121 mad7 bigenic (double transgenic) mice, Smad7 transgene expression reversed transforming growth factor
125 ndividuals harboring the transgene, and high transgene expression was observed in the blood of some P
127 completed in a few minutes and allows stable transgene expression within a few days, at success rates
130 itches with wide dynamic ranges that control transgene expression without the requirement of addition
131 shows exceptional cellular internalization, transgene expression, and low cytotoxicity compared to c
132 in vitro and in vivo assays with a focus on transgene expression, cell loss, and neuroinflammatory r
133 richment of recombinant cells independent of transgene expression, permitting the assessment of libra
134 and endogenous protein detection, along with transgene expression, the less abundant BRD4 short isofo
135 r development was prevented by forcing PDE7B transgene expression, while knockdown of PDE7B effective
136 Two mutations in nsP2 and nsP3 enhanced transgene expression, while three mutations in nsP3 regu
140 estoration of cell viability with a Bcl-x(L) transgene failed to rescue B cell development in Fnip1-d
141 expressing the Caenorhabditis elegans Fat-1 transgene (Fat-1(tg)xApoe(-/-)), which enables the endog
142 homing, incomplete penetrance of toxins and transgene fitness costs, each of which are of practical
143 Rescue from a different ClvR, they spread to transgene fixation in populations fixed for the latter a
145 integrates into a single, all-in-one vector transgenes for Cas9, sgRNA, and a fluorescence marker.
146 ic combinatorial co-transformation (up to 20 transgenes) for increasing C and N flows with the purpos
147 ometrically optimized DNA nanostructures for transgene-free and force-independent siRNA delivery and
148 ed SCAP-O and subclone SCAP-O(BCOR-mut) into transgene-free iPSCs using an excisable lentiviral vecto
149 ions were transmitted to at least 60% of the transgene-free T1 plants, with 33% of them containing bi
150 nd one of them, ClvR (n+1), carries a Rescue transgene from an earlier element, ClvR (n) ClvR (n+1) s
152 in mice lacking expression with and without transgenes generating amyloid-beta (Abeta) plaque pathol
153 elevated levels of GFAP from a human WT GFAP transgene has contributed to the notion that the mutatio
154 . aegypti mosquitoes harboring the anti-ZIKV transgene have significantly reduced viral infection, di
155 o genetic load resulting from the integrated transgenes impaired drive performance in the trials.
156 y of complex VSV recombinants carrying large transgenes.IMPORTANCE Vesicular stomatitis virus (VSV)-b
157 tion and gene therapies via AAV-delivered F8 transgene in an episome are costly and nonpermanent.
158 one by inserting the human lens alphaAN101D transgene in CRYalphaA(N101D) mice, and in the other by
161 , we tested whether expressing a therapeutic transgene in leukocyte progenitors that invade muscle wo
163 ably, neuronal expression of IkappaBalpha-SR transgene in mice expressing TDP-43(A315T) or TDP-43(G34
165 s in siRNAs derived from a PRSV coat protein transgene in the absence of virus replication showed the
167 utive expression of a miR159-resistant GAMYB transgene in tobacco resulted in phenotypes similar to t
168 we observed a strong immune response to the transgene in treated male Mecp2 mutant mice that was ove
170 the p53 or eqFP650 portions of virus-carried transgenes in any of the passaged viruses, demonstrating
174 /5 mutant phenotypes, and expression of ALA4 transgenes in pollen fully rescued ala6/7 mutant fertili
175 hat can be applied to constitutively express transgenes in specific cell types to examine their biolo
176 h allow for selection of multiple "unlinked" transgenes in the context of lentivirus-mediated transge
177 s essential for silencing different types of transgenes in the germ line and for suppressing the expr
178 umber of unexpected sequences in some of the transgenes, including undocumented cassettes and contami
179 y H2B-FP expression, occurring in all H2B-FP transgenes independent of label induction, accumulated w
180 ersed transforming growth factor (TGF)-beta1 transgene-induced inflammation, fibrosis, and subsequent
183 type seen in rTg4510 requires a ~70-copy tau-transgene insertion in a 244 kb deletion in Fgf14, a ~7-
184 in a 244 kb deletion in Fgf14, a ~7-copy tTA-transgene insertion in a 508 kb deletion that disrupts a
185 we report the first large-scale analysis of transgene insertion sites from 40 highly used transgenic
186 ut ready to go, cluster of P-element derived transgene insertions in Drosophila melanogaster, we show
188 livery and strong protein expression without transgene integration is accomplished in Nicotiana benth
189 C57BL/6 founder, suggesting that the UBC-GFP transgene integration site is closely linked to the MHC
190 ts the importance and urgency of mapping the transgene integration site of transgenic mouse strains u
191 ols has been proven by the identification of transgene integration sites and flanking sequences in th
192 assive delivery of genetic material, without transgene integration, into plant cells for diverse biot
195 tectal neuron type labeled by the id2b:gal4 transgene is a projection neuron that forms a stratified
196 ting transgenic mice where expression of the transgene is directed to these cells using the Eu promot
197 om the perspective of viral replication, the transgene is not only dispensable but may even be detrim
198 sue expression was observed with the Pf4-Cre transgene, leading to recombination in many hematopoieti
199 cient protein translation of the viral Mecp2 transgene, limits supraphysiological Mecp2 protein level
200 mbination labeling, inducible and reversible transgene manipulation, VCre recombinase expression, and
201 ine revertants that delete or inactivate the transgene may evolve to dominate the vaccine virus popul
202 ndogenous MCUb with a dominant-negative MCUb transgene (MCUb(W246R/V251E)) in vivo rescued T2D cardio
204 to 'maleness'-XX embryos could be rescued by transgene-mediated sex reversal or testosterone administ
206 P2 + P3) at 1 N level, and it also increased transgene methylation levels in codingregion (P2), and i
207 ound biomass, total soluble protein content, transgene methylation levels in promoterregion (P1), and
209 ion through the detection of AAV genomes and transgene mRNA, and show that intracellular and transmem
210 of a PTC and the nucleotide sequence of the transgene mRNA, which is homologous to the compensatory
213 onent configuration allows for combinatorial transgene optimization and increases safety by restricti
214 HBV (genotype D, serotype ayw)-either from a transgene or after infection with an adeno-associated vi
215 s that focus on a single receptor (using TCR transgenes) or a single specificity (using peptide-MHC t
218 n promoterregion but also in codingregion of transgene plays a critical role in transgene expression
219 ion in B6 mice homozygous for the PON1 human transgene [PON1Tg], PON1 knock-out mice [PON1KO], and wi
222 , efficient and fast whole-brain delivery of transgenes presents a persistent experimental challenge
225 er experiments in 2 participants showed that transgene-produced FVIII-SQ accelerated early factor Xa
230 s induced in newborn mice homozygous for the transgene Prom1(cre-ert2-nlacz) , which was knocked in t
231 NA transposons are more efficient with large transgenes, random integrations are potentially mutageni
233 Viral RNA replication from an endogenous transgene replicon system was not affected by lack of HI
234 ble for Orsay replication from an endogenous transgene replicon, suggesting that DRL-1 affects a prer
236 intersectional approach that involves three transgenes, requiring the intersection of two promoter/e
237 Tbx1(Cre) -activated expression of a Vegfr3 transgene rescued partially the cardiac lymphatic abnorm
238 Moreover, expression of Pnky from a BAC transgene rescues the differential gene expression and i
239 silence transcription, whereas a 5.5-kb Xist transgene robustly silenced transcription and read throu
241 e show that multiple DNA elements within the transgene sequences, including a metal response element
242 el alga Chlamydomonas have demonstrated that transgene silencing can be overcome by mutations in unkn
243 search has emphasized the risks of increased transgene silencing of Bacillus thuringiensis (Bt) rice
244 ly used reporter vectors and induces partial transgene silencing via the canonical and antiviral RNAi
249 injected systemically to deliver therapeutic transgenes site-specifically to diseased cells by respon
252 ctors typically use a B-domain-deleted FVIII transgene, such as human FVIII-SQ in valoctocogene roxap
253 pffer cells did not express the CSF1R-mApple transgene, suggesting that additional CSF1R transcriptio
254 pic expression of mouse or human Firre/FIRRE transgenes, supporting conserved trans-acting roles.
255 SIX proteins in host immunity, a human SIX1 transgene suppressed inflammation and promoted the recov
256 was observed as early as 4 weeks of age, and transgene suppression for the first 4 or 12 weeks of lif
261 dent of BAFF because of expression of a Bcl2 transgene) than in B6 wild-type mice despite the lower s
262 that could produce TIM proteins only from a transgene that cannot form the thermosensitive splicing
263 tation introduced into PHIL, a strain with a transgene that directs lineage-specific eosinophil ablat
264 Purification (TRAP)- approach and designed a transgene that expresses an eGFP-tagged ribosomal protei
265 three xenoantigens and to express nine human transgenes that enhance the pigs' immunological compatib
269 gineering) and the ability of the capsid and transgene to avoid the host immune response (by genetica
270 n, or yellow emission channels, allowing the transgene to be used with numerous reporters of gene exp
271 lls is reversible, we developed an inducible transgene to restore expression of DNMT3A in transplante
274 ble and fluorescent dCas9-KRAB and dCas9-VPR transgenes to allow for accurate quantification and trac
276 TIM4 mAbs in combination with CSF1R reporter transgenes to dissect the function of TIM4 in the chick
277 ucts such as plasmids, transposons, or other transgenes underlies many functional genomics measuremen
283 ulp during tooth development, the BSP-GFPtpz transgene was detected during in vitro mineralization of
284 onal degeneration so far; likely because the transgene was expressed in heterologous cell types.
285 was revealed when a B-cell antigen receptor transgene was found to circumvent the abnormal B-cell de
290 ockin and activation of tTA-driven responder transgenes was tested using four transgenic lines that e
293 specific tamoxifen-inducible Cre recombinase transgenes were used to target glioblastoma-relevant tum
294 we have developed a series of novel UAS-Cas9 transgenes, which allow fine tuning of Cas9 expression t
295 1 and Bxb1 integrase attP sites flanking the transgene will also enable rapid directional insertion o
299 We used SMC- and EC-specific Cre recombinase transgenes with a novel floxed Eln allele to focus gene
300 so enable rapid directional insertion of any transgene without a size limitation at the ROSA26 locus.